2008 Annual Meeting | Using AAN Guidelines and Best Current Evidence in Daily Practice: Neurocritical Care
02:15 PM - 03:00 PM |
Evidence-Based Medicine and Practice
Janis M. Miyasaki, MD, MEd, FAAN |
|
03:00 PM - 03:45 PM |
Evidence-Based Medicine Basics
Gary S. Gronseth, MD, FAAN |
|
03:45 PM - 04:00 PM |
Questions and Answers
|
|
04:00 PM - 04:15 PM |
Break
|
|
04:15 PM - 05:00 PM |
Prognosis in Coma
G. B. Young, MD, FAAN |
|
05:00 PM - 05:15 PM |
Questions and Answers
|
|
05:15 PM - 06:00 PM |
Imaging for Seizures in the Emergency Department
Cynthia L. Harden, MD |
|
06:00 PM - 06:15 PM |
Discussion
|
Cynthia L. Harden, MD | Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care. |
G. B. Young, MD, FAAN | No disclosure on file |
Gary S. Gronseth, MD, FAAN | Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN. |
Janis M. Miyasaki, MD, MEd, FAAN | Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council. |